OmniAb, Inc.

OABI

$4.75

-5.75%-$0.29

High—

Low—

52W High-12.5%

Rel. vol—

Interval

Range6.5h

Volume—SMA5SMA10

—

AI analysis

OmniAb, Inc. is showing mixed intraday momentum with consolidation near key moving averages and heightened sensitivity to liquidity shifts.

Upside confirmation strengthens on sustained reclaim above short-term trend anchors.
Breakdown risk rises if support fails with accelerating sell volume.
Relative strength versus sector peers remains neutral-to-slightly positive.

Latest indicator snapshot

Live technical and fundamental context, tuned for quick reads.

SMA5

$4.71

5-period simple moving average

SMA10

$4.69

10-period simple moving average

SMA20

$4.68

20-period simple moving average

SMA50

$4.70

50-period simple moving average

EMA5

$4.72

5-period exponential moving average

EMA10

$4.70

10-period exponential moving average

EMA20

$4.69

20-period exponential moving average

DEMA20

$4.70

Double exponential moving average

Fibonacci

Retracement

Retracement levels

VWAP

$4.77

Volume weighted average price

MACD

0.007

Signal -0.004

RSI(14)

78.9

Relative strength oscillator

OBV

-1.74K

On-balance volume

StochRSI

78.9 / 78.9

Fast oscillator pair

BBands Low

$4.62

Lower band

BBands Mid

$4.68

Middle band

BBands High

$4.74

Upper band

Market Cap

688.62M

Company size

P/E Ratio

0.00

Valuation multiple

EV / EBITDA

-10.62

Enterprise value multiple

ROE

-17.0%

Return on equity

ROA

-8.3%

Return on assets

Operating Margin

-49.5%

Operating efficiency

Net Margin

-115.1%

Bottom-line profitability

Current Ratio

—

Short-term liquidity

Debt / Equity

—

Balance-sheet leverage

Dividend Yield

0.0%

Income yield

FCF Yield

—

Free cash flow yield

Beta

1.22

Market sensitivity

52W High

$5.43

52-week peak

52W Low

$1.30

52-week trough

Supply Chain of OABI

Upstream / Downstream / Proxies

Upstream

GenScript Biotech CorporationHKEx:1548 Ligand Pharmaceuticals IncorporatedNASDAQ:LGNDContract Research Organization Network (US, Europe, Asia)Laboratory Animal Breeding & Production FacilitiesThermo Fisher Scientific Inc.NYSE:TMO Illumina, Inc.NASDAQ:ILMN 10x Genomics, Inc.NASDAQ:TXG Bio-Rad Laboratories, Inc.NYSE:BIO Danaher Corporation (Cytiva)NYSE:DHR Charles River Laboratories International, Inc.NYSE:CRL Revvity, Inc. (f/k/a PerkinElmer) — BioLegendNYSE:RVTY

Downstream

Janssen Pharmaceuticals (Johnson & Johnson)NYSE:JNJTakeda Pharmaceutical Company LimitedTSE:4502Gilead Sciences, Inc.NASDAQ:GILD Sanofi S.A.NASDAQ:SNYServierBaxter International Inc.NYSE:BAX Amgen Inc.NASDAQ:AMGN Merck & Co., Inc.NYSE:MRK Pfizer Inc.NYSE:PFE AbbVie Inc.NYSE:ABBVRoche Holding AG (Genentech)SWX:ROGBristol Myers Squibb CompanyNYSE:BMYNovartis AGSWX:NOVNDana-Farber Cancer InstituteMabtrx BiosciencesWyss Institute for Biologically Inspired Engineering (Harvard University)ArrowMark Partners / Viking Global Investors (NewCo)GenScript Biotech CorporationHKEx:1548

Proxies

AbCellera Biologics Inc.NASDAQ:ABCL Regeneron Pharmaceuticals, Inc.NASDAQ:REGN Ligand Pharmaceuticals IncorporatedNASDAQ:LGND Genmab A/SNASDAQ:GMAB

About UsPrivacy PolicyTerms of ServiceDisclaimerStock DirectoryETFsIndices13F HoldingsAnalyst TargetsFree ToolsTechnology MapJoin our Slack

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer